Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluating Real‐World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients

Clinical Transplantation(2024)10.1111/ctr.15480Source: DataRank Database

Evaluating Real‐World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients is a research paper published in Clinical Transplantation (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.16)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Varun K. Phadke ORCID,Stephanie M. Pouch ORCID,Aneesh K. Mehta ORCID,Geeta Karadkhele ORCID,Christian P. Larsen ORCID

Live enrichment

PubMed:39427300 PMC:PMC11889418 OpenAlex:https://openalex.org/W4403583218

National Institutes of Health

Grant: TL1TR002382

National Institutes of Health

Grant: UL1TR002378

National Institute of Allergy and Infectious Diseases

Grant: K23AI144036

National Center for Advancing Translational Sciences

FWCI

3.16

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ctr.15480

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ctr.15480

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.15480

journalhttps://doi.org/10.1111/ctr.15480

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39427300

Fields of Study

Cytomegalovirus and herpesvirus researchParvovirus B19 Infection StudiesViral-associated cancers and disorders

MeSH Terms

AdultAgedAntiviral AgentsBenzimidazolesCytomegalovirus InfectionsCytomegalovirusDichlororibofuranosylbenzimidazoleFemaleFollow-Up StudiesGraft RejectionGraft SurvivalHumansMaleMiddle AgedPostoperative ComplicationsPrognosisRetrospective StudiesRibonucleosidesRisk FactorsKidney TransplantationViral LoadDrug Resistance, ViralTransplant Recipients

Keywords

MedicineRefractory (planetary science)DiscontinuationInternal medicineViral loadTransplantationImmunosuppressionCytomegalovirusGastroenterologyRetrospective cohort studyImmunologyViral diseaseVirusHerpesviridaeCMVRenal Transplant RecipientsRefractory/resistant

Sustainable Development Goals

SDG 0: Good health and well-being